MENU
NOV 10, 2020 Opens: 8:00 AM EST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Modern Cell-Based Assays Virtual Symposium

Join us for presentations by scientists from leading labs in immuno-oncology, drug discovery, cell line development, and 3D/PDO models.

Learn how to conduct modern cell-based assays with varying culture models while maximizing the number of assays you can conduct as well as the number of measurable parameters. Streamline your workflow with diversified technology that can be utilized across a variety of research areas. Whether you are working with cell culture, 3D assays, virology assays, or advanced cell models there is something for you at this engaging event.

•    Attend free webinars with scientific innovators
•    View poster sessions to expand your knowledge base
•    Visit virtual booths and engage with other professionals
•    Chat with Field Application Scientists to gain insights
•    Win prizes and have fun

 


Speakers

Show Resources
You May Also Like
OCT 28, 2020 7:00 AM GMT, 12:30PM IST, 3:00PM SGT - SESSIONS WILL BE AVAILABLE FOR ON-DEMAND VIEWING IMMEDIATELY FOLLOWING THE LIVE BROADCAST.
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
OCT 28, 2020 7:00 AM GMT, 12:30PM IST, 3:00PM SGT - SESSIONS WILL BE AVAILABLE FOR ON-DEMAND VIEWING IMMEDIATELY FOLLOWING THE LIVE BROADCAST.
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Each step in a diagnostic test's journey-from raw material extraction to patient administration-can influence outcomes....
NOV 10, 2020
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 10, 2020
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Please join us for this FREE workshop, as we present Agilent’s LC/MS hardware and software solutions for getting the most out of your analysis data....
NOV 12, 2020 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
NOV 12, 2020 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Ten years ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2020 Clinical Diagnostics and Research Virtual Event will again bring together clinicians,...
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 7 th Ann...
NOV 11, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 11, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Twelveyears ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2021 Clinical Diagnostics and Research Virtual Event will again bring together clinician...
NOV 01, 2020
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 01, 2020
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
The ICIS Annual Meetings typically attract 650-750 registrants and have a distinguished history of presenting cutting edge research from internationally recognized scientists. This meeting e...
Agenda
Speakers

  • Mara Vinci, PhD
    Principal Investigator, Bambino Gesù Children's Hospital
    Biography

      Mara is a Principal Investigator at the Bambino Gesù Children's Hospital in Rome, where she leads the Pediatric High-Grade Glioma Group.  Prior to moving back to Italy Mara completed numerous postdoctoral positions at the Institute cancer research where her real focus was developing many 3D models and how these could be used to reduce animal usage and enhance translational medicine. Her talk will be focused on what imaging systems can be used to study complex biological systems.

    • Martin Thiess, PhD
      Field Application Scientist, Nexcelom Bioscience
      Biography

        Martin did a year of civil service at the Senckenberg Research Institute and Natural History Museum and went on to study Biology at Mainz University. Following a visit of Umeå University, Sweden for a year as ERASMUS scholar and thesis work at the Max Planck Institute for Brain Research he obtained his Diploma (MSc) in Mainz. His scientific career proceeded with a microscopy heavy PhD in developmental neurobiology from Heidelberg University which he completed with great honors (magna cum laude). After 3 years as Postdoc in the CellNetworks cluster of excellency he decided to continue his career as scientific support on the commercial side and currently supports Nexcelom as the Field Application Scientist for Germany, Austria, Switzerland (DACH).

      • Steve Rees
        Vice President Discovery Biology, AstraZeneca
        Biography

          Steve Rees is Vice-President of the Discovery Biology department at AstraZeneca with global responsibility for reagent generation, assay development and functional genomics.  Prior to this Steve led the Screening Sciences and Sample Management department at AstraZeneca with accountability for Compound Management, the human tissue BioBank, Hit Discovery and Lead Optimisation biology support to preclinical discovery projects.  Prior to joining AstraZeneca, Steve worked at GlaxoSmithKline for 24 years in various roles.   Steve has led multiple international collaborations, has authored >65 scientific papers and has spoken at many international symposia.

        • Jean Qiu
          Chief Technology Officer and Founder, Nexcelom Bioscience
          Biography

            Dr. Qiu earned her Ph.D. in Electrical Engineering from Purdue University in 1990 and conducted her postdoctoral research at 3M’s Corporate Research Lab. She is a pioneer of accurate cell counting methodologies, an inventor with 34 patents, and an accomplished researcher with over 45 publications in peer-reviewed academic journals. She is a member of the US Technical Advisory Group to the International Organization for Standardization (ISO) Technical Committee where she continuously contributes to the development of new cell counting and viability standards for a variety of challenging cell types in complex sample conditions.

          • Bjørn Gunnar Voldborg
            Director of CHO Cell Line Development, Technical University of Denmark
            Biography

              Bjørn Voldborg has more than 20 years of experience working with recombinant protein expression from both academic and industrial settings. Bjørn was team leader in the biotech company Pharmexa A/S, responsible for molecular cloning and expression of protein based drug candidates. From this he went to the NNF Center for Protein Research at the University of Copenhagen as Head of the Protein Production Unit, and since 2012 Bjørn has been heading the CHO Cell Line Engineering project at the NNF Center for Biosustainability at the Technical University of Denmark, a project dedicated to the engineering of improved protein production cell factories.

            • Henry Qazi, PhD
              Field Application Scientist, Nexcelom Bioscience
              Biography

                I received my PhD in Biomedical Engineering from CCNY/CUNY while developing and testing novel models for invasion and metastasis within the dynamic tumor microenvironment.  My diverse postdoctoral research allowed me to collaborate with multiple labs within Boston (MGH, HMS), New York (MSKCC, CCNY), and San Diego (VA, UCSD).  I am driven to engage with scientific leaders while providing support and resources to research professionals.  As your Field Application Scientist at Nexcelom, I continue my cross-functional role focused on sharing current research and offering better tools for advancing therapy and improving quality of life.

              • Rushika Perera, PhD
                Center for Vector-borne and Infectious Diseases, Colorado State University
                Biography

                  Rushika Perera is an arbovirologist with over twenty-five years of experience conducting studies on flaviviruses and alphaviruses. She has pioneered studies on the impact of host metabolism on viral infection. Using advanced mass spectrometry techniques, her research team has detailed the metabolic changes that occur in human and mosquito cells during infection with dengue viruses and have used functional studies to identify the host components involved in the process. These studies have also identified that specific host metabolic enzymes are hijacked by viral proteins to benefit the viral life cycle.

                • Suzanne Riches, PhD
                  Field Application Scientist, Nexcelom Bioscience
                  Biography

                    Suzanne first delved into the Cancer Research world after accepting a job at AstraZeneca following her bachelor’s degree in Biological Sciences. She continued with this line of research further and graduated with a PhD in Cancer Cell Biology from the University of Manchester. A four-year Post-Doctorate position in assay development led her to Nexcelom Bioscience where she has been working as an application scientist for the past two and a half years. Her expertise within Nexcelom includes Virology and Vaccine Development applications as well as high-throughput Oncology Assays and Accurate Cell Counting.

                  • James L Riley, PhD
                    Professor of Microbiology, University of Pennsylvania
                    Biography

                      James L. Riley, PhD, is an Professor of Microbiology at the University of Pennsylvania. His lab studies the cell biology and therapeutic use of primary human T cells. His lab has developed and is developing a number of T cell-based therapies to treat HIV, cancer and autoimmune diseases. As an officer in the US Army, he received postdoctoral training in Dr. Carl June’s laboratory, where he developed an interested in T cell signaling pathways and therapeutic uses of primary human T cells.  Dr. Riley graduated from Vanderbilt University with a BS in Molecular Biology, studying Dictyostelium iscoideum, and subsequently earned his PhD from Emory University in Dr. Jeremy Boss’ laboratory, studying the gene regulation of MHC class II genes.

                    • Andrea Love, PhD
                      Senior Business Development Manager, Nexcelom Bioscience
                      Biography

                        Andrea received her PhD in Immunology and Microbiology from New York Medical College. Her research focused on immune cell signaling and activation in the context of infectious disease, with particular emphasis on differential host-pathogen interactions. She joined Nexcelom in 2014 as a Field Applications Scientist, and currently serves as a Senior Business Development Manager, providing subject-matter expertise in the immunology and immuno-oncology research areas.

                      Help

                      General LabRoots Questions

                      email support@labroots.com  

                      Virtual Events and Webinars

                      Supported Configurations

                      • Operating System Internet Explorer Firefox Chrome Safari
                        Vista IE8+ FF10+ Chrome15+
                        Windows 7 IE8+ FF10+ Chrome15+
                        Windows 8 IE10 FF10+ Chrome15+
                        Mac OS X   FF10+ Chrome15+ Safari5.1+
                      • Cookie settings: session cookies enabled
                      • Browser configuration must have JavaScript enabled
                      • Adobe Flash player 10.2 or later

                      To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                      Internet Connection

                      • A minimum of 100Kbps is recommended for audio-only events
                      • A minimum of 300Kbps is recommended for speaker on-video events

                      Computer Equipment

                      • Screen Resolution: Minimum 1024x768
                      • Video Card: 65,000 colors minimum
                      • Sound card and speakers (or headphones) for hearing webcast in full format
                      • Audio Card: 16-bit minimum
                      • RAM: 512MB of free RAM

                      Firewall Protocol

                      • HTTP on port 80 or HTTPS on port 443
                      • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                      • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                      Work-At-Home Attendees

                      • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                      For A Seamless Experience

                      When using a mobile device, FREE Mobile Apps are available:

                      - For viewing Webinars:

                      - For viewing Virtual Events

                      Attendee Guide

                      • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                      Virtual Event and Webinar Support:

                      Continuing Education (CME/CE) Support

                      Loading Comments...
                      Show Resources
                      Event Countdown
                      • 0 Days
                      • 0 Hours
                      • 0 Minutes
                      • 0 Seconds
                      Attendees
                      • See more